Professor Alasdair MacGowan joins Charlotte Rowbottom, Senior Editor at eClinicalMedicine, to discuss treatment options for skin infections caused by MRSA, antimicrobial stewardship, and their research comparing the safety and efficacy of two therapeutic regimens.
Read the full article:
Oral minocycline plus rifampicin versus oral linezolid for complicated skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: the AIDA open label, randomized, controlled phase 4 trial
Continue this conversation on social!
Follow us today at...